Behcet’s disease: a review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20214828Keywords:
Behcet disease pathophysiology, Behcet treatment, VasculitisAbstract
Behcet's disease (BD) is a complex systemic vasculitis with an etiopathogenesis that remains unclear. It has a strong geographic association as well as a genetic propensity linked to the HLA-B51 factor and interactions between genetic and environmental factors. The typical age of onset is 25 to 40 years old and it is more common in men, who also have a more severe condition. Occlusive vasculitis is the hallmark of this condition, which can affect vessels of all diameters. Oral ulcers, genital ulcers, skin lesions, pathergy reaction as well as involvement of other systems and organs such as ophthalmic, neurological and vascular lesions, among others, are used to make the diagnosis. Uncontrolled neutrophil activation, activation of the humoral and cell immune systems, toxic proteins and infectious agents such as herpes simplex and streptococci are all involved in their pathophysiology. Due to the heterogeneity and several systems affected, the treatment is individualized and focused on treating each clinical manifestation.
References
Behcet H. Pediatric Behçet’s disease - clinical aspects and current concepts. Eur J Rheumatol. 2020;7(1):38-47.
Akdeniz N, Elmas ÖF, Karadağ AS. Behçet syndrome: a great imitator. Clinic Dermatol. 2019;37(3):227-39.
Behçet H. Einige Bemerkungen zu meinen Beobachtungen über den Tri-symptomenkomplex. Med Welt. 1939;13:1222-7.
Greco A, DeVirgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Behçet's disease: new insights into pathophysiology, clinical features and treatment options.Autoimmun Rev 2018;17(6):567-75.
Nair JR, Moots RJ. Behcet's disease. Clinic Med. 2017;17(1):71.
Cho SB, Cho S, Bang D. New insights in the clinical understanding of Behçet's disease. Yonsei Med J. 2012;53(1):35.
Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease: from East to West. Clinic Rheumatol. 2010;29(8):823-33.
Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet's disease in the US: a population‐based study. Arthritis Care Res.
;61(5):600-4.
Saavedra ER, Spiro GM, Mata J. El síndrome de Behcet en México. IMSS. 1985:459-63.
Criteria for diagnosis of Behcet’s disease. International Study Group Behcet’s Disease. Lancet. 1990;335(8697):1078-80.
International Team for the Revision of the International Criteria for Behcet’s Disease. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338-47.
International Team for the Revision of the International Criteria for Behçet's Disease (ITR‐ICBD), Davatchi F, Assaad‐Khalil S, Calamia KT,
Crook JE, Sadeghi‐Abdollahi B, et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338-47.
Rotondo C, Lopalco G, Iannone F, Vitale A, Talarico R, Galeazzi M, et al. Mucocutaneous involvement in behçet's disease: how systemic
treatment has changed in the last decades and future perspectives. Mediators Inflamm. 2015;2015:451675.
Soy M, Erken EREN, Konca K, Ozbek SÜLEY. Smoking and Behçet’s disease. Clinical Rheumatol. 2000;19(6):508-9.
Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet syndrome: a contemporary view. Nature Rev Rheumatol. 2018;14(2):107-19.
Al-Otaibi LM, Porter SR, Poate TWJ. Behçet’s disease: a review. J Dent Res. 2005;84(3):209-22.
Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, et al. Behçet syndrome. Nat Rev Dis Primers. 2021;7(1):67.
Gündüz Ö. Histopathological evaluation of Behçet's disease and identification of new skin lesions. Patholog Res Int. 2012;2012:209316.
Alpsoy E, Uzun S, Akman A, Acar MA, Memişoǧlu HR, Başaran E. Histological and immunofluorescence findings of non‐follicular papulopustular lesions in patients with Behçet's disease. J Eur Acad Dermatol Venereol. 2003;17(5):521-4.
Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu, et al. The pustular skin lesions in Behcet’s syndrome are not sterile. Ann Rheumat
Dis. 2004;63(11):1450-2.
Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, et al. Eye and Behçet's disease. J Francais D'ophtalmologie. 2019;42(4):133-46.
Fountain EM, Dhurandhar A. Neuro-Behçet's disease: an unusual cause of headache. J Gen Intern Med. 2014;29(6):956-60.
Borhani-Haghighi A, Kardeh B, Banerjee S, Yadollahikhales G, Safari A, Sahraian M, et al. Neuro-Behcet's disease: an update on diagnosis,
differential diagnoses, and treatment. Multiple Sclerosis Rel Disorder. 2019;39:101906.
Emmi G, Bettiol A, Silvestri E, DiScala G, Becatti M, Fiorillo C, et al. Vascular Behçet's syndrome: an update. Intern Emergen Med. 2919;14(5):645-52.
Seyahi E, Yazici H. Behçet's syndrome: pulmonary vascular disease. Curr Opin Rheumatol.2015;27(1):18-23.
Bicer A. Musculoskeletal findings in Behcet's disease. Pathol Res Int. 2012;2012:653806.
Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease. Curr Opin Rheumatol. 2015;27(1):24-31.
Akpolat T, Dilek M, Aksu K, Keser G, Toprak O, Cirit A et al. Renal Behçet's disease: an update. Seminar Arthritis Rheumatism. 2008;38(3):241-8.
Demirelli S, Degirmenci H, Inci S, Arisoy A. Cardiac manifestations in Behcet's disease. Intract Rare Dis Res. 2015;4(2):70-5.
Mattioli I, Bettiol A, Saruhan-Direskeneli G, Direskeneli H, Emmi G. Pathogenesis of Behçet's syndrome: genetic, environmental and immunological factors. Frontier Med.2021;8:713052.
Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheumat Dis. 2001;60:1002-996.
Rasha B, Ahmed W, Roba T, Abdoulmoktader A, Iman A. Microbial Infections as an etiology of Behcet’s disease. Int J Curr Microbiol Appl Sci. 2017;6:1694-7.
Hatemi G, Yazici H. Behçet’s syndrome and micro-organisms. Best Pract Res Clinic Rheumatol.2011;5:389-406.
Lule S, Colpak AI, Balci-Peynircioglu B, Gursoy-Ozdemir Y, Peker S, Kalyoncu T, et al. Behçet Disease serum is immunoreactive toneurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J Autoimmun. 2017;84:87-96.
Greco A, DeVirgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Behçet's disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567-75.
Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behçet's disease with special emphasis on the possible role of antigen presenting cells. Rheumatol Int. 2007;27:417-24.
Hatemi G, Christensen R, Bang D. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;77(6):808-18.
